Clinical Trials Browser

Phase 2 × Diarrhea × cabazitaxel × Clear all

NCT01469338 2014-11-24

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

Phase 2 Terminated

Diarrhea, Prostatic Neoplasms